Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
August 10, 2025
 · 
Be the first to react
A MyLymphomaTeam Member

I was actually wondering if there is anyone here that is on SubQ treatment and if it’s improved their IG levels and/or if they’ve had any side effects. I also have stage 3b CKD. My onc has been presuring me to start SubQ 1/week but I’m worried about my kidneys. I was told by the pharmacist in charge of the SubQ that I have a greater risk of going into renal failure. So I told my Onc NO. He wasn’t very happy about that. But it’s my body. My decision.

August 10, 2025
MyLymphomaTeam

Low immunoglobulin levels can occur after Rituxan (rituximab) therapy. This is because rituximab targets B-cells, which are responsible for producing immunoglobulins. When these levels become too low, it can affect your body's ability to fight infections.

Common symptoms of low immunoglobulin levels may include
• Frequent Show Full Answer

Low immunoglobulin levels can occur after Rituxan (rituximab) therapy. This is because rituximab targets B-cells, which are responsible for producing immunoglobulins. When these levels become too low, it can affect your body's ability to fight infections.

Common symptoms of low immunoglobulin levels may include:
• Frequent infections
• Fever
• Chills
• Generally feeling unwell
• Headaches Immunoglobulin levels can be monitored through blood tests called serum protein electrophoresis. If levels are found to be too low, your doctor may recommend immunoglobulin replacement therapy, which can be given subcutaneously (SubQ) to help support your immune system.

This is a recognized management approach for patients who have completed rituximab therapy and are experiencing low immunoglobulin levels. The treatment helps reduce the risk of infections while maintaining your remission status.

August 10, 2025

Related Questions

View All
A MyLymphomaTeam Member asked a question 💭
Frisco, TX